Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
09/04/2007 | US7264891 Stability, efficiency and color purity |
08/30/2007 | WO2007074477A3 Metaxalone polymorphs |
08/30/2007 | WO2007058338A9 Oxazole compound and pharmaceutical composition |
08/30/2007 | WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
08/30/2007 | US20070203339 Process for Preparation of Cyclic Prodrugs of PMEA and PMPA |
08/30/2007 | US20070203207 Heteroaromatic glucokinase activators |
08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
08/30/2007 | US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
08/30/2007 | CA2642650A1 Novel heterocyclic diphenyl ethers |
08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
08/29/2007 | EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
08/29/2007 | EP1824480A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
08/29/2007 | EP1824479A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
08/28/2007 | US7262316 by oxidation of aromatic hydroxymethyl, aromatic alkoxymethyl and/or aromatic aldehyde compounds in the presence of acid catalyst and ammonia or ammonium salts |
08/28/2007 | US7262303 Process for the production of chiral propionic acid derivatives |
08/28/2007 | US7262299 Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse |
08/28/2007 | US7262183 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases |
08/28/2007 | US7262156 1-Oxazolidin-3-yl-3-(o-amino- or hydroxyphenyl-propenone derivatives, e.g., 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for use in laundry detergents, perfumes, shampoos, and hair conditioners |
08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
08/23/2007 | WO2007094480A1 Method of producing optically active alcohol |
08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
08/23/2007 | US20070197788 Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases |
08/23/2007 | US20070197614 Method for the production of diarylcycloalkyl derivatives |
08/23/2007 | US20070197613 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (ppar) ligands for the treatment of hyperlipidemia and diabetes |
08/23/2007 | US20070197612 To modulate and control lipid and/or carbohydrate metabolism; atherosclerosis; acetic acid derivatives with cyclohexylmethoxy substituents; 2-[(1R,3S)-3-(2-Biphenyl-4-yl-5-methyloxazol-4-ylmethoxymethyl)cyclohexylmethoxy]-2-methylpropionic acid |
08/23/2007 | US20070197541 Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same |
08/23/2007 | US20070197472 N-Alkynyl-2-Heteroaryloxyalkylamides For Use As Fungicides |
08/23/2007 | CA2642388A1 Process for preparing optically active alcohols |
08/22/2007 | EP1819721A1 Microcin b17 analogs and methods for their preparation and use |
08/22/2007 | EP1819330A1 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
08/22/2007 | CN101020666A Prepn of florfenicol intermediate |
08/22/2007 | CN101019538A Prepn process of safe herbicide prepn of N-dichloroacetyl oxazolidine herbicide |
08/21/2007 | US7259263 Method of synthesis of azole-containing amino acids |
08/21/2007 | US7259262 Arylazole derivatives, their manufacture and use as pharmaceutical agents |
08/21/2007 | US7259178 Containing an oxazole ring, e.g., 1,1,1,3,3,3-Hexafluoro-2-{4-[[5-methyl-2-(3-trifluoromethyl-phenyl)-oxazol-4-ylmethyl]-(2,2,2-trifluoro-ethyl)-amino]-phenyl}-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
08/21/2007 | US7259177 Containing an oxazole ring 2-phenyl-, furanyl- or thiophenyl-substituted; e.g., 2,2-Dimethyl-4-[3-(5-methyl-2-p-tolyloxazol-4-ylmethoxy)cyclohexyl]-butyric acid; treating disorders of fatty acid metabolism, glucose utilization disorders, and also of disorders in which insulin resistance is involvolved |
08/21/2007 | US7259176 Process for the preparation of the insulin sensitizer |
08/21/2007 | US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis |
08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
08/16/2007 | WO2007091313A1 Cytokine production inhibitor and heterocyclic phenoxy derivative |
08/16/2007 | WO2007091009A2 Preparation of delmopinol |
08/16/2007 | US20070191447 Novel heterocyclic compound |
08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
08/16/2007 | US20070190325 Microcapsules with uv filter activity and process for producing them |
08/15/2007 | EP1818333A1 Vanilloid receptor ligands and their use in treatments |
08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
08/15/2007 | EP1817292A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
08/15/2007 | EP1532123B1 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
08/15/2007 | EP1354879B1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient |
08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
08/15/2007 | CN1331849C Novel method for synthesizing thiamphenicol and florfenicol and its key intermediate product |
08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
08/15/2007 | CN101016276A 5-nitro-2-difluoromethylbenzimidazole and synthesis method thereof |
08/15/2007 | CN101016275A 5-Amide-6-hydroxy-2-(4-carboxylphenyl)benzoxazole salt, synthesis and application |
08/15/2007 | CN101016274A 5-Chloro-2-difluoromethylbenzoxazole and synthesis method thereof |
08/15/2007 | CN101016273A 5-Chloro-2-difluorobromomethylbenzoxazole and synthesis method thereof |
08/14/2007 | US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors |
08/09/2007 | WO2007089044A1 Process for production of aromatic compound |
08/09/2007 | WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
08/09/2007 | WO2007014290B1 Fungicidal carboxamides |
08/09/2007 | US20070185132 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo |
08/09/2007 | CA2640454A1 Compounds and methods for modulating protein trafficking |
08/09/2007 | CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
08/08/2007 | EP1069127B1 Microencapsulated lewis acid |
08/08/2007 | CN1330641C Activator for peroxisome proliferator-responsive receptor delta |
08/08/2007 | CN101014714A Method for the production of diarylcycloalkyl derivatives |
08/08/2007 | CN101014581A Novel piperidine derivative for the treatment of depression |
08/08/2007 | CN101014579A 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and dia |
08/08/2007 | CN101014332A Agent for treatment of keratoconjunctive disorder |
08/08/2007 | CN101012205A 5-Methyl-2-trifluoromethyl benzoxazole and synthesis method thereof |
08/08/2007 | CN101012204A 5-Methyl-2-difluoromethyl benzoxazole and synthesis method thereof |
08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
08/07/2007 | CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i) |
08/07/2007 | CA2315397C Arylthiazolidinedione derivatives |
08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
08/07/2007 | CA2190256C Process for preparing aromatic or heteroaromatic sulfonyl halides |
08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
08/02/2007 | WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
08/02/2007 | WO2007085202A1 Oxamic acid derivatives,preparation methods and medical uses thereof |
08/02/2007 | WO2007063702A3 Iminopropene compound and use thereof |
08/02/2007 | WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
08/02/2007 | US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists |
08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
08/01/2007 | EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
08/01/2007 | EP1313715B1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
08/01/2007 | CN101007790A Oxamic acid derivative, and its preparation method and medicinal uses |
08/01/2007 | CN101007789A Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease |
07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
07/26/2007 | WO2007083320A2 Conversion of aromatic diazonium salt to aryl hydrazine |
07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
07/26/2007 | US20070173434 Antidiabetic oxazolidinediones and thiazolidinediones |